Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Technologies for translational imaging using generators in oncology.

Naomi R Schechter1, David J Yang, Ali Azhdarinia

  • 1Department of Radiation Oncology, The University of California San Francisco, San Francisco, California, USA. nschechter@radonc.ucsf.edu

Recent Patents on Anti-Cancer Drug Discovery
|January 29, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fibulin-4 expressed in metastatic breast cancer is a target of peptide-based imaging probes and experimental therapeutics.

Molecular therapy. Oncology·2026
Same author

Investigating machine learning algorithms to classify label-free images of pancreatic neuroendocrine neoplasms.

Biophotonics discovery·2026
Same author

Microplastics pollution in urban freshwater sediments: A descriptive assessment of land-use categories.

The Science of the total environment·2026
Same author

RBM39 Contributes to MGMT Maintenance in Response to Temozolomide-Induced DNA Damage.

Cancers·2025
Same author

Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications.

Current oncology (Toronto, Ont.)·2025
Same author

ACR-ABS-ACNM-ARS-SIR-SNMMI Practice Parameter for Radioembolization of Liver Malignancies.

American journal of clinical oncology·2025
Same journal

A Phase I Open-label Study of the Safety, Tolerability, and Pharmacokinetics of NHWD-870 HCl in Patients with Lymphoma and Other Advanced Solid Tumors.

Recent patents on anti-cancer drug discovery·2026
Same journal

Integrated Proteomics and Metabolomics Analysis Provides Insights into Metformin Down-regulating GLUL and SP1 to Inhibit Esophageal Squamous Cell Carcinoma Migration and Invasion.

Recent patents on anti-cancer drug discovery·2026
Same journal

SEZ6L2 Promotes Cervical Carcinogenesis by Activating the Wnt Signaling Pathway.

Recent patents on anti-cancer drug discovery·2026
Same journal

Shengma Biejia Decoction Suppresses Acute Myeloid Leukemia by Regulating Mitochondrial Dynamics through the PI3K/AKT Signaling Pathway.

Recent patents on anti-cancer drug discovery·2026
Same journal

Spatial and Single-cell Multi-omics Approaches Unravel the Genetic and Immunological Landscape of SIRPB1 in Kidney Renal Clear Cell Carcinoma.

Recent patents on anti-cancer drug discovery·2026
Same journal

Exploring the Active Components and Mechanisms of Schisandra Chinensis for Treatment of Non-small Cell Lung Cancer Based on Network Pharmacology and Experimental Validation.

Recent patents on anti-cancer drug discovery·2026
See all related articles

Developing targeted radiopharmaceuticals with generator-produced isotopes like 99mTc and 68Ga enhances tumor imaging. These advancements improve cancer diagnosis, prognosis, and treatment monitoring through molecular targeting.

Area of Science:

  • Nuclear medicine
  • Radiopharmaceutical chemistry
  • Molecular imaging

Background:

  • Scintigraphic tumor imaging relies on developing specific radiopharmaceuticals.
  • Functional pharmaceuticals are crucial for cancer diagnosis, prognosis, and treatment monitoring.
  • Generator-produced isotopes offer accessible and affordable options for molecular imaging.

Purpose of the Study:

  • To review the development and application of radiopharmaceuticals targeting molecular mechanisms in cancer.
  • To highlight the use of 99mTc and 68Ga for SPECT and PET imaging.
  • To discuss the potential of molecularly targeted agents in predicting and monitoring therapeutic response.

Main Methods:

  • Synthesis and evaluation of 99mTc- and 68Ga-labeled agents.

Related Experiment Videos

  • Assessment of radiotracers targeting molecular pathways: apoptosis, gene-based approaches, angiogenesis, hypoxia, and metabolism.
  • In vivo and human studies of developed imaging ligands.

    • Main Results:

    • Various molecular targets have been successfully imaged using 99mTc and 68Ga.
    • Labeled agents show potential for predicting and monitoring treatment response.
    • Demonstrated utility in differentiating tumor from non-tumor tissues.

    Conclusions:

    • Molecularly targeted radiopharmaceuticals using generator-produced isotopes significantly advance cancer imaging.
    • These agents hold promise for personalized cancer diagnosis and therapy.
    • Further research in molecular targets will refine cancer management strategies.